Figure (Cis0d 0000 01)
Cisplatin
Product Images NDC 65219-359
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cisplatin (NDC 65219-359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Cis0d 0000 02)
Figure (Cis0d 0000 03)
Cisplatin Injection 50 mg per 50 mL (1 mg per mL) vial label from Fresenius Kabi USA, LLC. The label notes that cisplatin doses greater than 100 mg/m2 once every 3 to 4 weeks are rarely used and advises to see the package insert. It states the product is cytotoxic and for intravenous use only. The label includes warnings to stop and verify the drug name and dose, specifies prescription use only, and shows a 50 mL multiple dose vial.*
Figure (Cis0d 0000 04)
Label for Cisplatin Injection BP 1 mg/ml, brand name KEMOPLAT by Fresenius Kabi USA, LLC. The packaging indicates a 50 mg/50 ml single-dose vial. The label includes cautions about handling and administration, storage instructions, and a barcode along with manufacturer details. The label design features purple, blue, and white colors.*
Figure (Cis0d 0000 05)
Cisplatin Injection 50 mg per 50 mL (1 mg per mL) vial label from Fresenius Kabi USA, LLC. The label contains highlighted safety information regarding dosage limits and warnings that the drug is a cytotoxic agent intended for intravenous use. The packaging indicates a multiple dose vial with a 50 mL volume, labeled for prescription use only.*
Figure (Cis0d 0000 06)
Cisplatin Injection BP 1 mg/ml (50 mg/50 ml) single dose vial label from Fresenius Kabi USA, LLC. The label includes warnings, usage instructions, storage conditions, and preservative information. The vial size is 50 ml.*
Figure (Cis0d 0000 07)
Cisplatin Injection 50 mg per 50 mL in a clear glass vial with a purple flip-off cap. The label shows the brand name CISplatin prominently, dosage strength, and administration instructions. The product is labeled by Fresenius Kabi USA, LLC.*
Figure (Cis0d 0000 08)
Cisplatin Injection EP 1 mg/ml, branded as Kemoplat, in a 50 ml glass vial. The vial label shows a dosage strength of 50 mg/50 ml and the product is labeled for single dose use. Manufactured or distributed by Fresenius Kabi USA, LLC, with product NDC 65219-359.*
Package Label – Principal Display Panel – Cisplatin Injection 50 mL Carton Panel (Cis0d 0000 09)
Packaging label for Cisplatin Injection BP 1 mg/ml in 50 mg/50 ml single dose vial form, branded as Kemoplat. Manufactured by Fresenius Kabi USA, LLC. The label includes dosage information, storage instructions, warnings about cytotoxicity and breastfeeding, and cautions about medical supervision and administration. The label features a barcode and the Fresenius Kabi logo.*
Package Label – Principal Display Panel – Cisplatin Injection 50 mL Vial Label (Cis0d 0000 10)
Cisplatin Injection BP 1 mg/ml Kemoplat single dose vial, 50 ml, by Fresenius Kabi USA, LLC. The label includes dosage information, storage instructions, warnings about cytotoxicity and breastfeeding, and cautions about proper medical supervision, with no antimicrobial preservatives.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
